Association of angiotensin-converting enzyme DD genotype with 24-h blood pressure abnormalities in normoalbuminuric children and adolescents with Type 1 diabetes

Diabetic Medicine

Volumn 22, Issue 8, 2005, Pages 1054-1059

  Barkai, László ^a   Soos A ^b   Vamosi I ^b  

^a Borsod County Teaching Hospital   (Hungary)

^b NONE

Author keywords

Ambulatory blood pressure measurement; Angiotensin converting enzyme gene polymorphism; Children and adolescents

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; INSULIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD PRESSURE MONITORING; CIRCADIAN RHYTHM; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GENE DELETION; GENE INSERTION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROTEINURIA; SCHOOL CHILD;

ADOLESCENT; BLOOD PRESSURE; CHILD; DIABETES MELLITUS, TYPE 1; FEMALE; GENOTYPE; HUMANS; HUNGARY; MALE; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; SEQUENCE DELETION;

EID: 22644435103     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2005.01601.x     Document Type: Article

References (49)

1. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potential risk factor for myocardial infarction. Nature 1992; 359: 641-644.
2. Markus HS, Barley J, Lunt L, Bland JM, Jeffery S, Carter ND et al. Angiotensin-converting enzyme gene deletion polymorphism: a new risk factor for lacunar stroke but not carotid atheroma. Stroke 1995; 26: 1329-1333.
3. Zee RY, Lou YK, Griffiths LR, Morris BJ. Association of a polymorphism of the angiotensin I-converting enzyme gene with essential hypertension. Biochem Biophys Res Commun 1992; 184: 9-15.
4. Kario K, Kanai N, Nishiuma S, Fujii T, Saito K, Matsuo T et al. Hypertensive nephropathy and the gene for angiotensin-converting enzyme. Arterioscler Thromb-Vasc Biol 1997; 17: 252-256.
5. Pontremoli R, Sofia A, Tirotta A, Ravera M, Nicolella C, Viazzi F et al. The deletion polymorphism of the angiotensin I-converting enzyme gene is associated with target organ damage in essential hypertension. J Am Soc Nephrol 1996; 7: 2550-2558.
6. Doria A, Warram JH, Krolewski AS. Genetic predisposition to diabetic nephropathy. Evidence for role of the angiotensin I-converting enzyme gene. Diabetes 1994; 43: 690-695.
7. Marre M, Bernadet P, Gallois Y, Savagner F, Guyene TT, Hallab M et al. Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 1994; 43: 384-388.
8. Parving H-H, Jacobsen P, Tarnow L, Rossing P, Lecerf L, Poirier O et al. Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study. Brit Med J 1996; 313: 591-594.
9. Penno G, Chaturvedi N, Talmud PJ, Cotroneo P, Manto A, Nannipieri M et al. Effect of angiotensin converting enzyme (ACE) gene polymorphism on progression of renal disease and the influence of ACE inhibition in IDDM patients: finding from the EUCLID Randomized Controlled Trial. EURODIAB Controlled Trial Lisinopril IDDM. Diabetes 1998; 47: 1507-1511.
10. Vleming LJ, van der Pijl JW, Lemkes HH, Westendorp RG, Maassen JA, Daha MR et al. The DD genotype of the ACE gene polymorphism is associated with progression of diabetic nephropathy to end stage renal failure in IDDM. Clin Nephrol 1999; 51: 133-140.
11. Azar ST, Zalloua PA, Medlej R, Halabi G. The DD genotype of the ACE gene polymorphism is associated with diabetic nephropathy in the type-1 diabetics. Endocr Res 2001; 27: 99-108.
12. Hadjadj S, Belloum R, Bouhanick B, Gallois Y, Guilloteau G, Chatellier G et al. Prognostic value of angiotensin-1 converting enzyme I/D polymorphism for nephropathy in type 1 diabetes mellitus: a prospective study. J Am Soc Nephrol 2001; 12: 541-549.
13. Rudberg S, Rasmussen LM, Bangstad H-J, Österby R. Influence of insertion/deletion polymorphism in the ACE-I gene on the progression of diabetic glomerulopathy in type 1 diabetic patients with microalbuminuria. Diabetes Care 2000; 23: 544-548.
14. Solini A, Vestra MD, Saller A, Nosadini R, Crepaldi G, Fioretto P. The angiotensin-converting enzyme DD genotype is associated with glomerulopathy lesions in type 2 diabetes. Diabetes 2002; 51: 251-255.
15. Powrie JK, Watts GF, Ingham JN, Taub NA, Talmud PJ, Shaw KM. Role of glycaemic control in development of microalbuminuria in patients with insulin dependent diabetes. Brit Med J 1994; 309: 1608-1612.
16. Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Lecerf L et al. Insertion/deletion polymorphism in the angiotensin-I-converting enzyme gene is associated with coronary heart disease in IDDM patients with diabetic nephropathy. Diabetologia 1995; 38: 798-803.
17. Pavlovic M, Reile M, Haeberle U, Schwarz K, Heinze E, Teller W et al. Angiotensin 1-converting enzyme-gene-polymorphism: relationship to albumin excretion and blood pressure in pediatric patients with type-1-diabetes mellitus. Exp Clin Endocrinol Diabetes 1997; 105: 248-253.
18. Björck S, Blohmé G, Sylvén C, Mulec H. Deletion insertion polymorphism of the angiotensin converting enzyme gene and progression of diabetic nephropathy. Nephrol Dial Transplant 1997; 12: 67-70.
19. Pfohl M, Frost D, Koch M, Clemens P, Patzies A, Schmulling RM et al. Lack of association between the insertion/deletion polymorphism of the angiotensin-converting-enzyme gene and diabetic nephropathy in IDDM patients. Horm Metab Res 1998; 30: 276-280.
20. De Cosmo S, Margaglione M, Tassi V, Garrubba M, Thomas S, Olivetti C et al. ACE, PAI-1, decorin and Werner helicase genes are not associated with the development of renal disease in European patients with type 1 diabetes. Diabetes Metab Res Rev 1999; 15: 247-253.
21. Frost D, Pfohl M, Clemens P, Haring H-U, Beischer W. Evaluation of the insertion/deletion ACE gene polymorphism as a risk factor for carotid artery intima-media thickening and hypertension in young type 1 diabetic patients. Diabetes Care 1998; 21: 836-840.
22. De Azevedo MJ, Dalmaz CA, Caramori ML, Pecis M, Esteves JF, Maia AL et al. ACE and PC-1 gene polymorphisms in normoal-buminuric Type 1 diabetic patients: a 10-year prospective study. J Diabetes Complications 2002; 16: 255-262.
23. Pavlovic M, Holl RW, Haeberle U, Schwarz K, Heinze E, Debatin K-M et al. Angiotensin I-converting enzyme and angiotensinogen gene polymorphisms related to 24-h blood pressure in pediatric type 1 diabetes mellitus. Eur J Pediatr 1999; 158: 18-23.
24. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents. Update on the 1987 task force report on high blood pressure in children and adolescents: a Working Group report from the national high blood pressure program. Pediatrics 1996; 98: 649-658.
25. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP 1) (dipeptidyl-carboxy peptidose 1). Nucleic Acids Res 1992; 20: 1433-1433.
26. Fogarty DG, Maxwell AP, Doherty CC, Hughes AE, Nevin NC. ACE gene typing. Lancet 1994; 343: 851.
27. Barkai L, Vámosi I, Lukács K. Enhanced progression of urinary albumin excretion in IDDM during puberty. Diabetes Care 1998; 21:1019-1023.
28. Barkai L, Madácsy L. Cardiovascular autonomic dysfunction in diabetes mellitus. Arch Dis Child 1995; 73: 515-518.
29. Barkai L, Kempler P, Vámosi I, Lukács K, Marton A, Keresztes K. Peripheral sensory nerve dysfunction in children and adolescents with type 1 diabetes mellitus. Diabet Med 1998; 15: 228-233.
30. Ruiz J, Blanché H, Cohen N, Velho G, Cambien F, Cohen D et al. Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin dependent diabetes mellitus. Proc Natl Acad Sci USA 1994; 91: 3662-3665.
31. Chowdhury TA, Dronsfield MJ, Kumar S, Gough SLC, Gibson SP, Khatoon A et al. Examination of two genetic polymorphisms within the renin-angiotensin system: no evidence for an association with nephropathy in IDDM. Diabetologia 1996; 39: 1108-1114.
32. Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, LaMotte F et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995; 332: 706-711.
33. Morris BJ, Zee RYL, Schrader AP. Different frequencies of angiotensin-converting enzyme genotypes in older hypertensive individuals. J Clin Invest 1994; 94: 1085-1089.
34. Schachter F, Faure-Delanef L, Guenot F, Rouger H, Froguel P, Lesueur-Ginot L et al. Genetic associations with human longevity at the ApoE and ACE loci. Nat Genet 1994; 6: 29-32.
35. Uemura K, Nakura J, Kohara K, Miki T. Association of ACE I/D polymorphism with cardiovascular risk factors. Hum Genet 2000; 107: 239-42.
36. Singer DRJ, Missouris CG, Jeffery S. Angiotensin-converting enzyme gene polymorphism: what to do about all the confusion? Circulation 1996; 94: 236-239.
37. Cambien F, Costerousse O, Tiret L, Poirier O, Lecerf L, Gonzalez MF et al. Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation 1994; 90: 669-676.
38. Pereira AC, Mota GF, Cunha RS, Herbenhoff FL, Mill JG, Krieger JE. Angiotensinogen 235T allele 'dosage' is associated with blood pressure phenotypes. Hypertension 2003; 41: 25-30.
39. Luik PT, Hoogenberg K, Kerstens MN, Beusekamp BJ, De Jong PE, Dullaart RP et al. The influence of the ACE (I/D) polymorphism on systemic and renal vascular responses to angiotensins in normotensive, normoalbuminuric Type 1 diabetes mellitus. Diabetologia 2003; 46: 1131-1139.
40. Rizzoni D, Muiesan ML, Montani G, Zulli R, Calebich S, Agabiti-Rosei E. Relationship between initial cardiovascular changes and daytime and night-time blood pressure monitoring. Am J Hypertens 1992; 5: 180-186.
41. Madacsy L, Yasar A, Tulassay T, Korner A, Kelemen J, Hobor M et al. Association of relative nocturnal hypertension and autonomic neuropathy in insulin-dependent diabetic children. Acta Biomed Ateneo Parmense 1995; 66: 111-118.
42. Lafferty AR, Werther GA, Clarke CF. Ambulatory blood pressure, microalbuminuria, and autonomic neuropathy in adolescents with type 1 diabetes. Diabetes Care 2000; 23: 533-538.
43. Hasslacher C, Steck W, Wahl P, Ritz E. Blood pressure and metabolic control as risk factors for nephropathy in type 1 (insulin-dependent) diabetes. Diabetologia 1985; 28: 6-16.
44. Mogensen CE, Christensen CK. Blood pressure changes and renal function changes in incipient and over diabetic nephropathy. Hypertension 1985; 7: II64-73.
45. Fujisawa T, Ikegami H, Kawaguchi Y, Hamada Y, Ueda H, Shintani M et al. Meta-analysis of association of insertion/deletion polymorphism of angiotensin I-converting enzyme gene with diabetic nephropathy and retinopathy. Diabetologia 1998; 41: 47-53.
46. Kennon B, Petric JR, Small M, Connell JM. Angiotensin-converting enzyme gene and diabetes mellitus. Diabet Med 1999; 16: 448-458.
47. Tarnow L, Gluud C, Parving H-H. Diabetic nephropathy and the insertion/deletion polymorphism of the angiotensin-converting enzyme gene. Nephrol Dial Transplant 1998; 13: 1125-1130.
48. Guntsche Z, Saravi FD, Reynals EA, Rauek B, Rauek M, Guntsche EM. Parental hypertension and 24-h blood pressure in children prior to diabetic nephropathy. Pediatr Nephrol 2002; 17: 157-164.
49. Kordonouri O, Danne T, Hopfenmuller W, Enders I, Hovener G, Weber B. Lipid profiles and blood pressure, are they risk factors for the development of early background retinopathy and incipient nephropathy in children with insulin-dependent diabetes mellitus? Acta Paediatr 1996; 85: 43-48.